中文
Company News
- Takara Bio Launches High-throughput, Cost-effective qPCR System to Advance Clinical Resear... 11/21/2024
- Takara Bio Europe Expands Existing Gothenburg Site to Offer Custom Enzyme Manufacturing 10/29/2024
- Launch of a Mutant RNA T7 Polymerase with Highly Reduced Double-stranded RNA Formation 5/16/2024
- Takara Bio Enters into a License Agreement of RetroNectin® with Fondazione Telethon E... 10/6/2023
- Takara Bio Europe Launched of New High Quality (HQ) Grade mRNA Production Enzymes "T7 RNA ... 9/16/2023
- Takara Bio Europe Announces Launch of CE-IVD Registered RT-qPCR Diagnostic Kit for SARS-Co... 10/9/2021
- Takara Bio Europe AB and Boston IVF Fertility Center Announce Partnership for Cell Therapy... 9/22/2021
- Takara Bio Enters into a License and Supply Agreement of RetroNectin® with BioNTech C... 6/25/2021